The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Blood Banks and Blood Centers (BB/BC) are playing a key role in the advancement of cell and biotherapies. BB/BC are working with pharmaceutical companies as our community advances these therapies to enhance the quality and safety of patient care. This demand necessitates infrastructure development at BB/BC. In this session the speakers will share experiences from 2 BB/BC. They will share their experiences including (1) contracts and budgets, (2) developing pricing, (3) information technology (IT) needs and challenges for Blood Establishment Computer System (BECS) tracking to integrating International Society of Blood Transfusion (ISBT) requirements and (4) how to track and handle compliance among different companies.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
Identify infrastructure needs for Blood Banks and Blood Centers (BB/BC) to develop a cell and biotherapy program.
Describe actions to overcome some of the challenges faced by BB/BC
List key items for developing a budget in a contract with a pharmaceutical company
Moderator(s):
Dr. Gay
Wehrli,
MD, MBA, MSEd,
University Hospitals, Samaritan Medical Center and Case Western
